Medipharm Labs Sees Canaccord Drop Price Target To $0.75
On May 17th, MediPharm Labs (TSX: LABS) Labs reported their first-quarter financials. The company announced revenue of 5.5 million, down
Read moreOn May 17th, MediPharm Labs (TSX: LABS) Labs reported their first-quarter financials. The company announced revenue of 5.5 million, down
Read moreMediPharm Labs (TSX: LABS) this morning continued its recent trend of dismal financing results, posting revenues of just $5.5 million
Read moreEarlier this week, Medipharm Labs (TSX: LABS) reported their fourth quarter and 2020 year-end financial results. The company announced revenue
Read moreMedipharm Labs (TSX: LABS) this morning reported its fourth quarter financial results for 2020. Revenues for the quarter amounted to
Read moreMedipharm Labs (TSX: LABS) has closed the bought deal financing that it announced and then later upsized earlier this week.
Read moreMedipharm Labs (TSX: LABS) has increased the size of the bought deal financing announced last night. Originally pegged at $20.0
Read moreMedipharm Labs (TSX: LABS) this evening announced that it will be conducting a bought deal financing. The financing will see
Read moreMedipharm Labs (TSX: LABS) this morning finally appointed a new chief financial officer, more than two months after the announced
Read moreMedipharm Labs (TSX: LABS) this morning announced drastic changes to its leadership role, with the major change being that CEO
Read moreYesterday, On November 16th, Medipharm Labs (TSX: LABS) reported their third quarter financial results. Reported revenues came in at $4.9
Read more